胃癌组织中Hras及Kras基因第12密码子点突变的检测及意义
胃癌,,],胃肿瘤;,ras基因;聚合酶链反应,1材料和方法,2结果,3讨论,[参考文献]
[摘要] 目的 探讨人胃癌组织中Hras、Kras基因第12密码子点突变情况及意义。方法 收集43例胃癌及相应癌旁组织标本。应用聚合酶链反应限制性片段长度多态性(PCRRFLP)分析法检测Hras、Kras基因第12密码子点突变情况。结果 43例胃癌组织中有1例发生Hras突变(1/43,2.3%),癌旁组织中未发生突变。Kras在胃癌及癌旁组织中均未发生突变。结论 胃癌组织中Hras、Kras基因第12密码子点突变率低,在胃癌的发生中不起主要作用。[关键词] 胃肿瘤; ras基因;聚合酶链反应
DETECTION OF POINT MUTATION OF CODON 12 OF Hras AND Kras IN GASTRIC CANCER TISSUESGU HUALI, DONG JING (Department of Emergency, The Affiliated Hospital of Qingdao University Medical College, Qingdao 266003, China)
[ABSTRACT]ObjectiveTo investigate the point mutation of codon 12 of Hras and Kras in tissues of gastric carcinoma. MethodsFortythree gastric cancer specimens and paraneoplastic tissues were obtained. Point mutation in codon 12 of Hras and Kras were detected by polymerase chain reactionrestriction fragment length polymorphism (PCRRFLP). ResultsOne case (1/43, 2.3%) of mutation of Hras 12 codon was detected, no mutation was found in paraneoplastic. No mutation of Kras was detected in both cancer and paraneoplastic tissues. ConclusionThe point mutation rate of codon 12 of Hras and Kras is low in gastric cancer, which suggestive of little role in the genesis of the cancer. ......
您现在查看是摘要页,全文长 7507 字符。